Literature DB >> 2184933

Cancer predisposition of ataxia-telangiectasia heterozygotes.

M Swift1, C L Chase, D Morrell.   

Abstract

Ataxia-telangiectasia (A-T) is a progressive neurologic disorder in which there is varied immune dysfunction, an excess sensitivity to ionizing radiation, and a striking predisposition to cancer. It is the autosomal recessive syndrome for which there is the strongest evidence, derived from retrospective studies of cancer incidence and mortality in A-T families, that the heterozygote is predisposed to cancer. We present, in tabular form, the specific cancer sites or types most likely to be associated with A-T heterozygosity. These include solid tumors of the breast, pancreas, stomach, bladder, and ovary, and chronic lymphocytic leukemia. We also introduce a new method to test these associations. As soon as molecular probes for the A-T allele(s) are available, this new research design will be used to test rigorously each association, hypothesized on the basis of previous data, between a specific cancer site and A-T heterozygosity.

Entities:  

Mesh:

Year:  1990        PMID: 2184933     DOI: 10.1016/0165-4608(90)90004-t

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  15 in total

1.  The Aspergillus nidulans musN gene encodes a RecQ helicase that interacts with the PI-3K-related kinase UVSB.

Authors:  A F Hofmann; S D Harris
Journal:  Genetics       Date:  2001-12       Impact factor: 4.562

2.  Effective testing of gene-disease associations.

Authors:  M Swift; L L Kupper; C L Chase
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

Review 3.  ATM, radiation, and the risk of second primary breast cancer.

Authors:  Jonine L Bernstein; Patrick Concannon
Journal:  Int J Radiat Biol       Date:  2017-07-27       Impact factor: 2.694

Review 4.  Pancreatic adenocarcinoma: epidemiology and genetics.

Authors:  T Y Flanders; W D Foulkes
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

Review 5.  Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.

Authors:  Ryan J Stubbins; Sophia Korotev; Lucy A Godley
Journal:  Curr Hematol Malig Rep       Date:  2022-06-08       Impact factor: 4.213

6.  Risk of other cancers in individuals with a family history of pancreas cancer.

Authors:  Michele L Cote; Maryjean Schenk; Ann G Schwartz; Fawn D Vigneau; Margaret Kinnard; Joel K Greenson; Jon P Fryzek; Gui Shuang Ying; David H Garabrant
Journal:  J Gastrointest Cancer       Date:  2007

Review 7.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  CT and MR imaging of splenic leiomyoma in a child with ataxia telangiectasia.

Authors:  M Coşkun; U Aydingöz; T Tacal; M Ariyürek; F Demirkazik; L Oğuzkurt
Journal:  Pediatr Radiol       Date:  1995

9.  Gene expression signatures but not cell cycle checkpoint functions distinguish AT carriers from normal individuals.

Authors:  Liwen Zhang; Dennis A Simpson; Cynthia L Innes; Jeff Chou; Pierre R Bushel; Richard S Paules; William K Kaufmann; Tong Zhou
Journal:  Physiol Genomics       Date:  2013-08-13       Impact factor: 3.107

Review 10.  Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer.

Authors:  A M Taylor
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.